Meeting of the National Vaccine Advisory Committee, 3204 [05-1135]

Download as PDF 3204 Federal Register / Vol. 70, No. 13 / Friday, January 21, 2005 / Notices of this collection of information, including suggestions for reducing this burden to Ms. Jeanette Thornton, GSA Desk Officer, OMB, Room 10236, NEOB, Washington, DC 20503, and a copy to the Regulatory Secretariat (VIR), General Services Administration, Room 4035, 1800 F Street, NW., Washington, DC 20405. Please cite OMB Control No. 3090–0163, Information Specific to a Contract or Contracting Action (not required by regulation), in all correspondence. SUPPLEMENTARY INFORMATION: A. Purpose The General Services Administration (GSA) has various mission responsibilities related to the acquisition and provision of supplies, transportation, ADP, telecommunications, real property management, and disposal of real and personal property. These mission responsibilities generate requirements that are realized through the solicitation and award of public contracts. Individual solicitations and resulting contracts may impose unique information collection/reporting requirements on contractors, not required by regulation, but necessary to evaluate particular program accomplishments and measure success in meeting special program objectives. B. Annual Reporting Burden Respondents: 126,870 Responses Per Respondent: 1.36 Total Responses: 172,500 Hours Per Response: .399 Total Burden Hours: 68,900 OBTAINING COPIES OF PROPOSALS: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VIR), 1800 F Street, NW., Room 4035, Washington, DC 20405, telephone (202) 208–7312. Please cite OMB Control No. 3090–0163, Information Specific to a Contract or Contracting Action (not required by regulation), in all correspondence. Dated: January 13, 2005. Laura Auletta, Director, Contract Policy Division. [FR Doc. 05–1084 Filed 1–19–05; 8:45 am] BILLING CODE 6820–61–S HARRY S. TRUMAN SCHOLARSHIP FOUNDATION Harry S. Truman Scholarship 2005 Competition Harry S. Truman Scholarship Foundation. AGENCY: VerDate jul<14>2003 14:11 Jan 19, 2005 Jkt 205001 Notice of closing for nominations from eligible institutions of higher education. ACTION: SUMMARY: Notice is hereby given that, pursuant to the authority contained in the Harry S. Truman Memorial Scholarship Act, Public Law 93–642 (20 U.S.C. 2001), nominations are being accepted from eligible institutions of higher education for 2005 Truman Scholarships. Procedures are prescribed at 45 CFR part 1801. In order to be assured consideration, the Truman Scholarship Foundation, 712 Jackson Place, NW., Washington, DC 20006, must receive all documentation in support of nominations no later than February 7, 2005, from participating institutions. Dated: January 11, 2005. Louis H. Blair, Executive Secretary. [FR Doc. 05–1048 Filed 1–19–05; 8:45 am] BILLING CODE 6820–AD–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary. ACTION: Notice. AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. DATES: The meeting will be held on February 8, 2005, from 9 a.m. to 4 p.m., and on February 9, 2005, from 9 a.m. to 4 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, Room 725H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; (202) 690–5566, nvac@osophs.dhhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Assistant Secretary for Health, as the Director of the National Vaccine Program, on matters related to the program’s responsibilities. Topics to be discussed at the meeting include influenza control, polio eradication and vaccine stockpiles, vaccine safety, and vaccine supply. Updates will be given on the NVAC Working Group on Public Participation, the NVAC Vaccine Safety and Communications Subcommittee, the NVAC Futures Vaccines Subcommittee, and the NVAC Immunization Coverage Subcommittee. A tentative agenda will be made available on or about January 25, 2005 for review on the NVAC Web site: https://www.hhs.gov/nvpo/nvac. Public attendance at the meeting is limited to space available. Individuals must provide a photo ID for entry into the Humphrey Building. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business February 1, 2005. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail nvac@osophs.dhhs.gov. Dated: January 12, 2005. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. 05–1135 Filed 1–19–05; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [ATSDR–206] Availability of Final Toxicological Profiles Agency for Toxic Substances and Disease Registry (ATSDR), AGENCY: E:\FR\FM\21JAN1.SGM 21JAN1

Agencies

[Federal Register Volume 70, Number 13 (Friday, January 21, 2005)]
[Notices]
[Page 3204]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1135]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on February 8, 2005, from 9 a.m. to 4 
p.m., and on February 9, 2005, from 9 a.m. to 4 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Room 725H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 690-5566, 
nvac@osophs.dhhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human 
Services was mandated to establish the National Vaccine Program to 
achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Assistant 
Secretary for Health, as the Director of the National Vaccine Program, 
on matters related to the program's responsibilities.
    Topics to be discussed at the meeting include influenza control, 
polio eradication and vaccine stockpiles, vaccine safety, and vaccine 
supply. Updates will be given on the NVAC Working Group on Public 
Participation, the NVAC Vaccine Safety and Communications Subcommittee, 
the NVAC Futures Vaccines Subcommittee, and the NVAC Immunization 
Coverage Subcommittee. A tentative agenda will be made available on or 
about January 25, 2005 for review on the NVAC Web site: https://
www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, through the contact person listed above prior to close of 
business February 1, 2005. Preregistration is required for both public 
attendance and comment. Any individual who wishes to attend the meeting 
and/or participate in the public comment session should e-mail 
nvac@osophs.dhhs.gov.

    Dated: January 12, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-1135 Filed 1-19-05; 8:45 am]
BILLING CODE 4150-28-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.